Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Comparator Balances from Mettler Toledo
Wednesday, October 08, 2014
Increased pressure on calibration laboratories to comply with industry regulations, such as United States Pharmacopeia (USP) Chapter 41 and Good Manufacturing Practice, have led to a growing demand for weight calibration.

Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A
Wednesday, October 08, 2014
Optimized kit for use with Gyros immunoassay platform.

ARTES, InstrAction and Q-Biologicals Join Forces
Tuesday, October 07, 2014
Three-party consortium for vaccine developments for veterinary applications.

New Methodology for CHN Determination of Liquid Samples
Tuesday, October 07, 2014
Exeter Analytical’s application note demonstrates the utility of Model 440 CHN microanalysis system.

New Compact SIMS - Mass Spectrometry in Solid Material
Saturday, October 04, 2014
Designed for fast and easy characterization of layer structures, surface contamination and impurities.

New SLE and SPE Automation System from Biotage - Flexible, Simple and Reliable
Saturday, October 04, 2014
New Biotage® Extrahera™ for the processing of SLE and SPE methods in both plate and column formats.

Bio-Rad Introduces the New ZOE™ Fluorescent Cell Imager
Saturday, October 04, 2014
Fluorescence microscopy now as easy as using a tablet.

Protea Biosciences and InSphero Successful in Mass Spectrometry Imaging of 3D Microtissues
Saturday, October 04, 2014
Protea to present data at upcoming InSphero User Group Meetings.

Micro Droplet Systems from Dolomite
Saturday, October 04, 2014
Provide automatic, seamless production of monodispersed droplets.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 10592
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv